C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof

Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526)
11/2002
11/14/2002	WO2002090541A1 Determination of a genetic predisposition for behavioural disorders
11/14/2002	WO2002090540A1 Ethylene insensitive plants
11/14/2002	WO2002090537A1 Process for synthesizing protein using cell-free protein synthesis system
11/14/2002	WO2002090535A1 Methods and compositions comprising renilla gfp
11/14/2002	WO2002090534A1 Method for treating neurodegenerative, psychiatric and other disorders with deacetylase inhibitors
11/14/2002	WO2002090532A1 Novel mutation
11/14/2002	WO2002090529A1 Dna molecules encoding macaca mulatta androgen receptor
11/14/2002	WO2002090526A2 Human secreted proteins
11/14/2002	WO2002090520A2 Toll/interleukin-1 receptor adaptor protein (tirap)
11/14/2002	WO2002090519A2 Mutant p21?cip1/waf1¿ and cell growth control
11/14/2002	WO2002090518A2 Differential regulation of t cell survival and proliferation
11/14/2002	WO2002090508A2 Cell adhesion-mediating proteins and polynucleotides encoding them
11/14/2002	WO2002090506A2 Metabolite transporters
11/14/2002	WO2002090504A2 Novel antibodies that bind to antigenic polypeptides, nucleic acids encoding the antigens, and methods of use
11/14/2002	WO2002090502A2 Highly conserved proteins from gram-positive bacteria
11/14/2002	WO2002090500A2 Novel human proteins, polynucleotides encoding them and methods of using the same
11/14/2002	WO2002090499A2 ss-AMYLOID PEPTIDE-BINDING PROTEINS AND POLYNUCLEOTIDES ENCODING THE SAME
11/14/2002	WO2002090495A2 Rapidly cleavable sumo fusion protein expression system for difficult to express proteins
11/14/2002	WO2002090494A2 Isolation, characterization, cloning and use of a mushroom lectin
11/14/2002	WO2002090491A2 Modification of metal-handling in plants
11/14/2002	WO2002090388A1 Derivatives of exendin
11/14/2002	WO2002090387A1 Reproductive cancer diagnosis and therapy
11/14/2002	WO2002090386A2 Regulatory protein involved in pectin modification
11/14/2002	WO2002090385A1 Protein polymer having unfold activity on higher-order structure of protein
11/14/2002	WO2002090384A2 Antimicrobial polypeptide from aspergillus niger
11/14/2002	WO2002090383A2 M. catarrhalis antigens
11/14/2002	WO2002090382A2 Mixture of peptides derived from e6 and/or e7 papillomavirus proteins and uses thereof
11/14/2002	WO2002090381A1 Chemokine-binding proteins for treating congestive heart failure
11/14/2002	WO2002090379A1 Process for inactivating prions in lipoproteins
11/14/2002	WO2002090377A2 Peptides that bind to dna and inhibit dna replication, and methods of use
11/14/2002	WO2002090376A1 Lectin protein prepared from korean marine crab philyra pisum, process for preparing the same and the use thereof
11/14/2002	WO2002090373A1 Human sperm activator peptides
11/14/2002	WO2002090330A1 Substituted 2-pyridine-cyclohexane-1,4-diamine derivatives
11/14/2002	WO2002090317A1 Substituted cyclohexane-1,4-diamine derivatives
11/14/2002	WO2002089840A1 Recombinant bicistronic flaviviruses and methods of use thereof
11/14/2002	WO2002089837A1 Chimeric human leukocyte antigen and epitope-bearing molecules having immunosuppressant activity
11/14/2002	WO2002089831A1 Preventives/remedies for nephritis
11/14/2002	WO2002089817A2 Anti-virus agent
11/14/2002	WO2002089783A1 Substituted cyclohexan-1,4-diamine derivatives with constipating and peripheral analgesic properties
11/14/2002	WO2002089764A2 Gelatin substitute
11/14/2002	WO2002089747A2 Compositions and methods for the therapy and diagnosis of prostate cancer
11/14/2002	WO2002089733A2 Recombinant orf2 proteins of the swine hepatitis e virus and their use as a vaccine and as a diagnostic reagent for medical and veterinary applications
11/14/2002	WO2002089731A2 Agents for treatment of hcv and methods of use
11/14/2002	WO2002089728A2 Recombinant rhabdoviruses as live-viral vaccines
11/14/2002	WO2002089727A2 Methods of using cytokine c17
11/14/2002	WO2002089586A1 Lung epithelial cell line for propagating viruses
11/14/2002	WO2002089561A1 Tyra genes and uses thereof
11/14/2002	WO2002089555A2 Methods and compositions to modulate ethylene sensitivity
11/14/2002	WO2002081694A8 Method for the sectetion and production of protein
11/14/2002	WO2002077010A9 Method of preventing t-cell mediated responses by map proteins
11/14/2002	WO2002076174A3 Fbh58295fl, a novel human amino acid transporter and uses thereof
11/14/2002	WO2002074904A3 Rearranged squamous cell carcinoma antigen genes ii
11/14/2002	WO2002074326A3 Urocortin-iii and uses thereof
11/14/2002	WO2002072605A3 Expression technology for proteins containing a hybrid isotype antibody moiety
11/14/2002	WO2002072603A3 Novel human dectin proteins and polynucleotides encoding the same
11/14/2002	WO2002072126A3 Invention relating to hcv diseases
11/14/2002	WO2002068667A3 Regulatory elements from rp1 gene and uses thereof
11/14/2002	WO2002068465A9 Novel p53-inducible protein
11/14/2002	WO2002068457A3 Antiangiogenic peptides derived from endostatin
11/14/2002	WO2002066628A3 Supersecretable peptides, processes for their production, and parallel improvement of the secreted form of one or more other polypeptides
11/14/2002	WO2002066604A3 Avian mago nashi gene
11/14/2002	WO2002064779A3 Peptide inhibitors of cellular proliferation
11/14/2002	WO2002062370A3 Stabilization of hypoallergenic, hyperdigestible previously reduced proteins
11/14/2002	WO2002061081A9 A novel gene bn01 mapping to chromosome 16q24.3
11/14/2002	WO2002053585A3 Mammalian nuclear receptor cofactor cf11 and methods of use
11/14/2002	WO2002051233A3 Universal antimicrobial treatment
11/14/2002	WO2002050116A3 Adhesion molecule protein
11/14/2002	WO2002049422A3 Non-human animal disease models
11/14/2002	WO2002046215A3 Basb221 polypeptides and polynucleotides encoding basb221 polypeptides
11/14/2002	WO2002040692A3 Specific promoter of the human vascular endothelial cadherin-2 (hve-cad-2) gene and the therapeutic uses thereof
11/14/2002	WO2002032944A3 Basb208 nucleotide and amino acid sequences from haemophilus influenzae
11/14/2002	WO2002029048A3 Regulation of human sodium-dependent neurotransmitter transporter
11/14/2002	WO2002022650A3 Haplotypes of the per1 gene
11/14/2002	WO2002018623A3 Methods and reagents for protease inhibition
11/14/2002	WO2002015661A8 Inhibitors of hiv replication and method of treatment of hiv infections
11/14/2002	WO2002008413A3 Cytochrome b5 gene and protein of candida tropicalis and methods relating thereto
11/14/2002	WO2002006464B1 Large scale expression and purification of recombinant proteins
11/14/2002	WO2001036659A3 Selectable cell surface marker genes
11/14/2002	WO2001031036A9 Modified viral surface proteins which bind to cells of tumor vasculature
11/14/2002	WO2001029179A3 Regulation of gene expression by neuromodulators
11/14/2002	WO2001021636A9 Identification of a vaccine candidate from an extraintestinal isolate of e. coli
11/14/2002	US20020170094 Nucleotide sequences coding polypeptide for use in generating disease resistant plants
11/14/2002	US20020170093 Nucleotide sequences coding polypeptide for use in the generation of preferential phenotype in plants
11/14/2002	US20020170089 Nucleic acids encoding defense inducible proteins and uses thereof
11/14/2002	US20020170088 Nucleotide sequences coding polypeptide for use in propagation control in plants
11/14/2002	US20020170087 Transcriptional regulator nucleic acids, polypeptides and methods of use thereof
11/14/2002	US20020170085 Methyl CpG binding domain nucleic acids from maize
11/14/2002	US20020170082 Genetically engineered plants for use as tools in the propagation of preferential plants in agriculture
11/14/2002	US20020170081 Transgenic animal for use in the diagnosis, evaluation and treatment of tension
11/14/2002	US20020170080 Animal model for use in the evaluation and treatment of atherosclerosis
11/14/2002	US20020170079 Polypeptide for use in the treatment, prevention ad diagnosis of tumors
11/14/2002	US20020170077 Nucleotide sequences coding polypeptide for use in te diagnosis, prevention and treatment of atherosclerosis, ischemia/ reperfusion injuries, hypertension, restenosis and arterial inflammation
11/14/2002	US20020169308 Nucleotide sequences coding membrane protein for use in the human diagnostics and therapeutics
11/14/2002	US20020169307 Transgenic mice containing LPR5 gene disruptions
11/14/2002	US20020169305 Nucleotide sequences coding polypeptide for use in the treatment and prevention of malaria
11/14/2002	US20020169303 Novel PTP-20, PCP-2, BDP1, CLK, and SIRP proteins and related products and methods
11/14/2002	US20020169302 Compositions isolated from bovine mammary gland and methods for their use
11/14/2002	US20020169301 Nucleotide sequences coding polypeptide for use in the diagnosis and treatment of cell proliferative disorders
11/14/2002	US20020169300 Nucleotide sequences coding polypeptide for use in the diagnosis and treatment of colon cancer
11/14/2002	US20020169299 Gene for identifying individuals with familial dysautonomia

1 ... 1718 1719 1720 1721 1722 1723 1724 1725 1726 1727 1728 1729 1730 1731 1732 1733 1734 1735 1736 1737 1738 ... 2916